Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40161 | ISIN: US74275C3043 | Ticker-Symbol:
NASDAQ
27.03.24
18:36 Uhr
2,350 US-Dollar
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PROCESSA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
PROCESSA PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur PROCESSA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:18Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference1
DiProcessa Pharmaceuticals Inc expected to post a loss of $1.60 a share - Earnings Preview1
MoProcessa Pharmaceuticals, Inc.: Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting2
21.02.Processa Pharmaceuticals, Inc. - 8-K, Current Report2
21.02.Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference1
14.02.Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference1
09.02.How Is The Market Feeling About Processa Pharma?-
08.02.Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying2
06.02.Processa Pharmaceuticals regains Nasdaq compliance-
06.02.Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule2
06.02.Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule157HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next generation...
► Artikel lesen
06.02.Processa Pharmaceuticals, Inc. - 8-K, Current Report-
01.02.Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering1
29.01.Panbela Therapeutics, Processa Pharmaceuticals among healthcare movers8
29.01.PCSA, TCBP and NXU among pre-market losers11
26.01.What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?2
26.01.Processa Pharmaceuticals prices discounted stock and warrants offering to raise $7M3
26.01.TCBP and PCSA among pre-market losers11
26.01.Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering1
26.01.ACON, PCSA and CORZ among pre-market losers14
Seite:  Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1